How To Use CPT Code 0082U

CPT 0082U describes a proprietary laboratory analysis (PLA) test that is used to analyze a urine specimen for the presence or absence of 90 or more drugs, drug metabolites, or other substances. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples of CPT code 0082U.

1. What is CPT Code 0082U?

CPT 0082U is a unique code that represents a specific laboratory test known as NextGen Precision™ testing from Precision Diagnostics. This test utilizes instrumented chemistry analyzers to analyze a urine specimen for the presence or absence of 90 or more drugs, drug metabolites, or other substances. It provides a report that includes descriptions and severity of significant interactions between these substances.

2. Official Description

The official description of CPT code 0082U is a proprietary laboratory analysis (PLA) test that uses instrument chemistry analyzers to perform presumptive drug tests and definitive chromatography with mass spectrometry. The test is conducted on a urine specimen and provides a report of the presence or absence of each drug, drug metabolite, or substance, along with descriptions and severity of significant interactions per date of service.

3. Procedure

1. The laboratory analyst performs the technical steps of the drug screening procedure using instrumented chemistry analysis.
2. The test includes presumptive identification of any number of drug classes using immunoassays, such as enzyme-linked immunosorbent assay (ELISA), or other immunoassay methods.
3. Definitive chromatography, such as gas chromatography (GC) or liquid chromatography (LC), is used to separate components in the specimen.
4. Mass spectrometry (MS) is employed to identify the components and their amounts in the mixture.
5. The analyst prepares a report that includes the presence or absence of each drug, drug metabolite, or substance, along with descriptions and severity of significant interactions per date of service.

4. Qualifying circumstances

CPT code 0082U is used when clinicians order this test to determine the severity of significant interactions between 90 or more drugs, drug metabolites, and other substances. It is important to note that this test is specific to the NextGen Precision™ testing from Precision Diagnostics, and should only be reported for this particular test.

5. When to use CPT code 0082U

CPT code 0082U should be used when the NextGen Precision™ testing from Precision Diagnostics is performed on a urine specimen to analyze the presence or absence of 90 or more drugs, drug metabolites, or substances. It should not be used for any other laboratory tests or procedures.

6. Documentation requirements

To support a claim for CPT code 0082U, the laboratory should document the following information:

• Date of service
• Specific details of the test performed, including the use of instrument chemistry analyzers, presumptive drug tests, definitive chromatography, and mass spectrometry
• Presence or absence of each drug, drug metabolite, or substance
• Descriptions and severity of significant interactions

7. Billing guidelines

When billing for CPT code 0082U, it is important to use the code only for the NextGen Precision™ testing from Precision Diagnostics. Report one unit of this code for a single specimen analyzed on a single date of service. It should not be reported with any other CPT codes. Some payers may pay separately for the collection of the specimen, so it is advisable to check with the appropriate payer for their specific guidelines.

8. Historical information

CPT code 0082U was added to the Current Procedural Terminology system on January 1, 2019. There have been no updates or changes to the code since its addition.

9. Examples

1. A laboratory performs the NextGen Precision™ testing from Precision Diagnostics on a urine specimen to analyze the presence or absence of 90 or more drugs, drug metabolites, or substances.
2. A clinician orders the NextGen Precision™ testing from Precision Diagnostics to determine the severity of significant interactions between various drugs and substances in a patient’s urine sample.
3. The NextGen Precision™ testing from Precision Diagnostics is used to analyze a urine specimen for the presence or absence of 90 or more drugs, drug metabolites, or substances in order to assess potential interactions and their severity.
4. A patient undergoes the NextGen Precision™ testing from Precision Diagnostics to determine the presence or absence of specific drugs, drug metabolites, or substances in their urine sample and evaluate the severity of any significant interactions.
5. The NextGen Precision™ testing from Precision Diagnostics is performed on a urine specimen to identify the presence or absence of 90 or more drugs, drug metabolites, or substances and assess the severity of potential interactions.
6. A laboratory utilizes the NextGen Precision™ testing from Precision Diagnostics to analyze a urine specimen for the presence or absence of various drugs, drug metabolites, or substances and provide a report on the severity of significant interactions.
7. A clinician orders the NextGen Precision™ testing from Precision Diagnostics to evaluate the presence or absence of 90 or more drugs, drug metabolites, or substances in a patient’s urine sample and assess the severity of potential interactions.
8. The NextGen Precision™ testing from Precision Diagnostics is performed on a urine specimen to determine the presence or absence of specific drugs, drug metabolites, or substances and evaluate the severity of any significant interactions.
9. A patient undergoes the NextGen Precision™ testing from Precision Diagnostics to identify the presence or absence of 90 or more drugs, drug metabolites, or substances in their urine sample and assess the severity of potential interactions.
10. The NextGen Precision™ testing from Precision Diagnostics is utilized to analyze a urine specimen for the presence or absence of various drugs, drug metabolites, or substances and provide a comprehensive report on the severity of significant interactions.